* Re-submission of Rizaport NDA to FDA is expected in first
half of 2017
The post BRIEF-Redhill Biopharma provides 2017 semi-annual business update appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Re-submission of Rizaport NDA to FDA is expected in first
half of 2017
The post BRIEF-Redhill Biopharma provides 2017 semi-annual business update appeared first on NASDAQ.